NDC product
Naproxen Sodium Diphenhydramine HCl
NDC 69842-328 · CVS PHARMACY, INC
Key facts
| Product NDC | 69842-328 |
|---|---|
| Proprietary name | Naproxen Sodium Diphenhydramine HCl |
| Nonproprietary name | Naproxen Sodium Diphenhydramine HCl |
| Substances | NAPROXEN SODIUM, DIPHENHYDRAMINE HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | CVS PHARMACY, INC |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA213663 |
| Pharmacologic classes | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC] |
| Marketing start | May 14, 2021 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: